These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6306206)

  • 1. Determination of pKa values of some prototropic functions in mitomycin and porfiromycin.
    Underberg WJ; Lingeman H
    J Pharm Sci; 1983 May; 72(5):553-6. PubMed ID: 6306206
    [No Abstract]   [Full Text] [Related]  

  • 2. MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.
    IYER VN; SZYBALSKI W
    Science; 1964 Jul; 145(3627):55-8. PubMed ID: 14162693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of the chemical stability of mitomycin and porfiromycin in acidic solution.
    Underberg WJ; Lingeman H
    J Pharm Sci; 1983 May; 72(5):549-53. PubMed ID: 6864504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PORFIROMYCIN.
    DUVALL LR
    Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of mechanisms proposed for the conversion of mitomycins into mitosenes.
    Iyengar BS; Remers WA
    J Med Chem; 1985 Jul; 28(7):963-7. PubMed ID: 3925148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
    Musser SM; Pan SS; Callery PS
    J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
    Pan SS; Iracki T
    Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
    Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
    Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CROSSLINKING OF DNA BY ENZYMATICALLY OR CHEMICALLY ACTIVATED MITOMYCINS AND PORFIROMYCINS, BIFUNCTIONALLY "ALKYLATING" ANTIBIOTICS.
    SZYBALSKI W; IYER VN
    Fed Proc; 1964; 23():946-57. PubMed ID: 14209827
    [No Abstract]   [Full Text] [Related]  

  • 11. New mitomycin analogs produced by directed biosynthesis.
    Claridge CA; Bush JA; Doyle TW; Nettleton DE; Moseley JE; Kimball D; Kammer MF; Veitch J
    J Antibiot (Tokyo); 1986 Mar; 39(3):437-46. PubMed ID: 3700245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of mitomycin C and porfiromycin by Streptomyces species.
    Mandwal AK; Subramanian PM; Bhatia MC; Kapil RS; Popli SP; Vora VC
    J Nat Prod; 1985; 48(2):334. PubMed ID: 3925088
    [No Abstract]   [Full Text] [Related]  

  • 14. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):456-60. PubMed ID: 8552660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE PHYSICAL CHEMICAL CHARACTERIZATION OF THE PRODUCTS, EQUILIBRIA, AND KINETICS OF THE COMPLEX TRANSFORMATIONS OF THE ANTIBIOTIC PORFIROMYCIN.
    GARRETT ER
    J Med Chem; 1963 Sep; 6():488-501. PubMed ID: 14173567
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of new mitomycin C and porfiromycin analogues.
    Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
    J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
    Na Y; Wang S; Kohn H
    J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.